Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis
Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis
复制标题
DOI：
10.1191/1352458503ms902oa
复制
发表时间：
2003-01-01
影响因子：
5.8
通讯作者：
Weinstock-Guttman, B
中科院分区：
文献类型：
--
作者：
Benedict, RHB;Fishman, I;Weinstock-Guttman, B
简介：贝克抑郁量表快速筛查 (BDI-FS) 是一个简短的自我报告量表，旨在评估患有内科疾病的患者的抑郁症。由于抑郁症在多发性硬化症 (MS) 中尤为突出，因此迫切需要一种经济有效的方法来识别 MS 中的抑郁症。 BDI-FS 在这方面可能有用，但迄今为止，其在多发性硬化症患者中的有效性尚未得到评估。方法：对 54 名连续 MS 患者进行了研究。所有人都接受了心理评估，其中包括 BDI-FS 和其他抑郁症自我报告指标。使用神经精神病量表 (NPI) 采访了 48 名护理人员/线人。回顾性图表审查是由一名训练有素的研究助理进行的，对心理测试和访谈的结果视而不见，以确定是否开了抗抑郁药物。结果：BDI-FS 与其他自我报告的抑郁症指标（P < 0.001）以及知情者报告的烦躁情绪显着相关（P < 0.01），此外，BDI-FS 评分可区分正在接受抑郁症治疗的 MS 患者和未经治疗的 MS 患者（P = 0.01）。结论：这些数据支持 BDI-FS 在 MS 中的并发和区分有效性。由于该测试简短且不会与神经系统症状混淆，因此建议对该人群进行抑郁症筛查。
Introduction:The Beck Depression Inventory-Fast Screen (BDI-FS) is a brief self-report inventory designed to evaluate depression in patients with medical illness. As depressive disorder is especially prominent in multiple sclerosis ( MS), a cost-effective procedure for identifying depressive disorder in MS is sorely needed. The BDI-FS may be useful in this regard although, to date, its validity in MS patients has not been assessed. Methods: Fifty-four consecutive MS patients were studied. All underwent psycho logical assessment, which included the BDI-FS and other self-report measures of depression. Forty-eight caregiver/informants were inter viewed using the Neuorpsychiatric Inventory (NPI). Retrospective chart reviews were conducted by a single trained research assistant, blind to the results of psychological testing and inter views, to determine if antidepressant medications had been prescribed. Results: The BDI-FS was significantly correlated with other self-report measures of depression (P < 0.001) and with informant reported dysphoria (P < 0.01), In addition, BDI-FS scores discriminated MS patients undergoing treatment for depressive disorder from untreated MS patients ( P = 0.01). Conclusion: These data support the concurrent and discriminative validity of the BDI-FS in MS. As the test is brief and not confounded with neuro logical symptoms, it is recommended for depression screening in this population.